You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

small cell lung cancer,Utidelone

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced or Metastatic NSCLC Trial (Utidelone Injection, Docetaxel Injection)

Not yet recruiting
  • Locally Advanced or Metastatic Non-Small Cell Lung Cancer
  • Utidelone Injection
  • Docetaxel Injection
  • (no location specified)
Dec 30, 2022

Advanced NSCLC Trial in Beijing, Harbin, Tianjin (utidelone injection)

Completed
  • Advanced Non-small Cell Lung Cancer
  • utidelone injection
  • Beijing, Beijing, China
  • +3 more
Jan 8, 2023

SCLC, Extensive Stage Trial in Zhengzhou (Utidelone, Placebo)

Recruiting
  • SCLC, Extensive Stage
  • Zhengzhou, Henan, China
    Henan Tumor Hospital
Mar 24, 2022

Double-dose Furmonertinib in Treatment of Slow

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • (no location specified)
Oct 31, 2023

NSCLC Trial in Shanghai

Not yet recruiting
  • Non-small Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Jul 20, 2023

    NSCLC, EGFR Gene Mutation, EGFR-TKI Resistant Mutation Trial (Nintedanib, gefitinib, erlotinib, afatinib)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • +2 more
    • Nintedanib, gefitinib, erlotinib, afatinib
    • (no location specified)
    Oct 2, 2023

    Extensive Stage Small Cell Lung Cancer (ES-SCLC) Trial (HS-20093)

    Not yet recruiting
    • Extensive Stage Small Cell Lung Cancer (ES-SCLC)
    • (no location specified)
    Sep 19, 2023

    NSCLC, Neoadjuvant Therapy, Radiotherapy Trial in Yangzhou (drug, radiation, other)

    Recruiting
    • Non-small Cell Lung Cancer
    • +3 more
    • Yangzhou, Jiangsu, China
      People's hospital of northern jiangsu
    Sep 26, 2023

    TRAcking Non-small Cell Lung Cancer Evolution Through Therapy

    Not yet recruiting
    • Lung Cancer, Non-small Cell
    • Small Cell Lung Cancer
      • (no location specified)
      Nov 16, 2022

      Stage II-IIIB(N2) NSCLC Trial in Shanghai (TQB2450, Carboplatin, Pemetrexed)

      Not yet recruiting
      • Stage II-IIIB(N2) Non-small Cell Lung Cancer
      • Shanghai, Shanghai, China
        Shanghai Pulmonary Hospital
      Oct 26, 2023

      Extensive Stage Small Cell Lung Cancer Trial (hSTC810 400 mg + Paclitaxel, hSTC810 800 mg + Paclitaxel)

      Not yet recruiting
      • Extensive Stage Small Cell Lung Cancer
      • hSTC810 400 mg + Paclitaxel
      • hSTC810 800 mg + Paclitaxel
      • (no location specified)
      Aug 24, 2023

      Relapsed Small Cell Lung Cancer Trial in Beijing (Irinotecan HCl liposome Injection, Topotecan)

      Not yet recruiting
      • Relapsed Small Cell Lung Cancer
      • Irinotecan hydrochloride liposome Injection
      • Topotecan
      • Beijing, China
        Cancer Hospital, Chinese Academy of Medical Sciences
      Nov 7, 2023

      Small Cell Lung Cancer Trial (Tarlatamab)

      Available
      • Small Cell Lung Cancer
      • (no location specified)
      Sep 26, 2023

      Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer

      Recruiting
      • Small Cell Lung Cancer
      • Biospecimen Collection
      • Indianapolis, Indiana
      • +1 more
      Jun 2, 2023

      Identify Resected Non-small-cell Lung Cancer With High Risk of

      Recruiting
      • Non-small Cell Lung Cancer Stage IIIA
      • Resected non small cell lung cancer
      • Toulouse, France
        Julien MAZIERES
      Feb 8, 2023

      Specific Protein Overexpression in Adult Non-Small Cell Lung

      Not yet recruiting
      • Non Small Cell Lung Cancer
        • (no location specified)
        Sep 29, 2023

        Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

        Not yet recruiting
        • Metastatic Lung Non-Small Cell Carcinoma
        • +2 more
        • Cetuximab
        • +2 more
        • Sacramento, California
          University of California Davis Comprehensive Cancer Center
        Oct 2, 2023

        Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Zhengzhou (ZG006)

        Not yet recruiting
        • Small Cell Lung Cancer
        • Neuroendocrine Carcinoma
        • ZG006
        • Zhengzhou, Henan, China
          Henan Cancer Hospital
        Aug 6, 2023

        NSCLC Trial (BGB-A445, Docetaxel, Tislelizumab)

        Not yet recruiting
        • Non-Small Cell Lung Cancer
        • (no location specified)
        Sep 6, 2023

        NSCLC Trial (Tirelizumab;Chemotherapy monotherapy)

        Not yet recruiting
        • Non-small Cell Lung Cancer
        • Tirelizumab；Chemotherapy monotherapy
        • (no location specified)
        Jul 27, 2023

        Limited-stage Small Cell Lung Cancer (LS-SCLC) Trial in Jinan (Tifcemalimab injection, toripalimab injection, Placebo for

        Not yet recruiting
        • Limited-stage Small Cell Lung Cancer (LS-SCLC)
        • Tifcemalimab injection
        • +3 more
        • Jinan, Shandong, China
          Shandong Cancer Hospital & Institute
        Oct 18, 2023

        Non Small Cell Lung Cancer, NSCLC, Lung Cancer Trial in Port Saint Lucie, Greenville (BL-B01D1)

        Recruiting
        • Non Small Cell Lung Cancer
        • +2 more
        • Port Saint Lucie, Florida
        • +1 more
        Aug 11, 2023

        Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer, Stage II Lung Cancer Trial in Nashville (drug, biological,

        Not yet recruiting
        • Limited Stage Lung Small Cell Carcinoma
        • +3 more
        • Nashville, Tennessee
          Vanderbilt University/Ingram Cancer Center
        Nov 10, 2023

        Extensive Small Cell Lung Cancer Trial in Jinan (Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy)

        Recruiting
        • Extensive Small Cell Lung Cancer
        • Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy
        • Jinan, Shan Dong, China
          The First Affiliated Hospital of Shandong First Medical Universi
        Nov 6, 2023

        NSCLC Trial in Guangzhou (BL-M07D1)

        Not yet recruiting
        • Non-small Cell Lung Cancer
        • Guangzhou, Guangdong, China
          Sun Yat-sen University Cancer Center
        Nov 1, 2023